Unitika Ltd. engages in the polymer and functional materials business. It operates through the following business segments: Polymer, Functional Material, Fiber, and Others. The Polymer segment manufactures and sells plastic film, resin, and non-woven cloth. The Functional Material segment handles the manufacture and sale of glass fibers. The Fiber segment deals with the manufacture and sale of various fibers such as thread, cotton, and knitted fibers. The Others segment includes environmental business, medical business, lifestyle and wellness, and real estate businesses. The company was founded on June 19, 1889 and is headquartered in Osaka, Japan.

Istituto Gentili SpA, part of Neopharmed Gentili SpA, is an Italian company located in Pisa. The firm develops pharmaceutical products. It was acquired by Mediolanum Farmaceutici SpA from Merck & Co., Inc. on July 31, 2009.

Shangluo Wei'an Industrial Co., Ltd., established on 2005-08-01, Business scope includes general items:Chinese herbal medicine planting;real estate herbal medicine(Does not contain Chinese herbal medicine)buy and sell;livestock sales;Feed Additive Sales;Animal Husbandry and Fishery Feed Sales;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;Production of Chinese herbal extracts;Sales of building materials;General merchandise sales;tea planting;hotel management;Catering Management;property management;Fermentation process optimization technology research and development;food sales(Only sell prepackaged food);Sales of agricultural and sideline products;Horticultural Products Planting;Gardening Product Sales;Landscaping engineering construction(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Feed additive production;feed production;wine production;Construction Engineering Construction;animal husbandry;accommodation service;Catering Services;Production of tea products;food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Shenzhen Fengyu Biomedical Technology Co., Ltd., established on 2020-04-16, Business scope includes general business items:medicine,functional food,one,two,Class III Medical Devices,Technology development of health products,technical consulting;cosmetic,Chemical Products(Does not contain dangerous goods)promotion of;food research and development;Invest in business(Specific projects will be reported separately);Domestic Trade,Operating import and export business(Does not contain franchise,Exclusive control,Monopoly).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments),The licensing program is:food sales;Pre-packaged food,Wholesale and retail of health food.

Shaanxi Hongde Agriculture and Forestry Technology Co., Ltd., established on 2009-05-07, Business scope includes general items:tea planting;Chinese herbal medicine planting;fruit planting;Horticultural Products Planting;vegetable planting;Crop Cultivation Services;Primary processing of edible agricultural products;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;Bio-organic fertilizer research and development;Research and development of biopesticide technology;Bio-feed R&D;Retailing of Edible Agricultural Products;Sales of agricultural and sideline products;Tea set sales;Metal Ore Sales;Chinese herbal medicine acquisition;Botanic Garden Management Services;Zoo Management Services;Rural folk crafts and products,Development and management of leisure agriculture and rural tourism resources(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan.

W. L. Gore & Associates has made its name by creating innovative, technology-driven solutions, from medical devices that treat aneurysms to high-performance GORE‑TEX® fabrics. A privately held company with annual sales of more than $3 billion, Gore is committed to perpetuating its 50-plus year tradition of product innovation. Gore focuses its efforts in four main areas: electronics, fabrics, industrial and medical products. The company’s electronic products division develops and manufactures high-performance copper and optical signal transmission products. Gore’s fabrics provide protection from the elements and enable wearers to remain comfortable across a broad range of activities and conditions. The products made by Gore’s industrial division meet diverse contamination control and processing challenges throughout industry. Implants from the medical division provide creative healing solutions to complex medical problems. Today, Gore employs more than 10,000 employees, called associates, with manufacturing facilities in the United States, Germany, the United Kingdom, Japan and China, and sales offices around the world.

Retrotope creates a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases. It is a privately held company focused on the development of ways of controlling metabolic processes associated with oxidative stress conditions. Retrotope uses isotope effect to slow down damaging pathways. The company has several discovery and development programs that involve major classes of biopolymers, with the major focus on neurological diseases such as Friedreich's ataxia. It was founded in 2006 and is located in Los Altos Hills, California.

Tianjin Institute of Pharmaceutical Research Co., Ltd. engages in the in the development of various new products such as innovative drugs, generic drugs, new preparations, traditional Chinese medicines, and biological drugs with particular emphasis on the engineering and industrialization of new technologies to meet drug registration requirements. The company was founded in 1959 and is headquartered in Tianjin, China.

R-Tech Ueno Ltd. engages in the research and development, manufacture and sale of pharmaceutical products. It operates through the following business divisions: New Pharmaceutical Research and Development, Pharmaceutical Manufacture and Sale, and Pharmaceutical Development Support and Contract Manufacturing Services. The New Pharmaceutical Research and Development business provides development for unmet medical needs area, orphan drug area, and anti-aging area. The Pharmaceutical Manufacture and Sale business handles the manufacture and sale of Rescula Eye Drops for glaucoma and ocular hypertension. The Pharmaceutical Development Support and Contract Manufacturing Services business covers the manufacture and sale of AMITIZA capsules for chronic idiopathic constipation. It also accepts contract manufacturing of eye drops, liquid drugs and liquid-filled hard capsules. The company was founded by Ryuji Ueno and Sachiko Kuno in September 1989 and is headquartered in Tokyo, Japan.

National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON.

Part of Pfizer Inc., Wyeth Lederle Japan Ltd is a company headquartered in Tokyo, Japan, specializing in pharmaceutical preparations. Wyeth Corp., now a subsidiary of Pfizer Inc. acquired Wyeth Lederle Japan Ltd from Takeda Pharmaceutical Co., Ltd. on May 21, 2003.

Part of Zunyi Medical University, Affiliated Hospital of Zunyi Medical College is a company headquartered in Zunyi, China. The firm provides medical services.

Jiangsu Yikai Medical Equipment Co., Ltd., established on 2013-12-05, The scope of business includes two types of6866Production of medical polymer materials and products,processing,Sales(Operate according to the business scope and period listed in the license);medical catheter,Production of Class I Medical Devices,processing,Sales;Self-operated and agent import and export business of the above commodities.(Except for goods that are restricted by the state to be operated by enterprises or prohibited from import and export);daily mask(non-medical)Production;daily mask(non-medical)Sales;Production of Class II Medical Devices;Wholesale of Class II Medical Devices;Retailing of Class II Medical Devices;(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tokyo Tanabe Co. Ltd., a subsidiary of Cegedim SA, is a Japanese company located in Tokyo. The firm produces and sells medicines.

Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL.